{"id":558690,"date":"2024-06-26T14:24:05","date_gmt":"2024-06-26T12:24:05","guid":{"rendered":"https:\/\/www.capgemini.com\/es-es\/?post_type=research-and-insight&#038;p=558690"},"modified":"2025-03-12T07:58:53","modified_gmt":"2025-03-12T06:58:53","slug":"impulsando-exito-time-to-market-desarrollo-clinico-farmacos","status":"publish","type":"research-and-insight","link":"https:\/\/www.capgemini.com\/es-es\/investigacion\/biblioteca-de-investigacion\/impulsando-exito-time-to-market-desarrollo-clinico-farmacos\/","title":{"rendered":"Impulsando el \u00e9xito y el time-to-market en el desarrollo cl\u00ednico de f\u00e1rmacos"},"content":{"rendered":"\n<header class=\"wp-block-cg-blocks-hero-reusable header heroReusable  \"><div class=\"header-bgs\"><picture><source srcset=\"https:\/\/www.capgemini.com\/wp-content\/uploads\/2024\/01\/Next-Gen-clinical-development.jpg?w=2880&amp;quality=70 1x, https:\/\/www.capgemini.com\/wp-content\/uploads\/2024\/01\/Next-Gen-clinical-development.jpg?w=2880&amp;quality=70 2x\" media=\"(min-width: 1500px)\"\/><source srcset=\"https:\/\/www.capgemini.com\/wp-content\/uploads\/2024\/01\/Next-Gen-clinical-development.jpg?w=1440&amp;quality=70 1x, https:\/\/www.capgemini.com\/wp-content\/uploads\/2024\/01\/Next-Gen-clinical-development.jpg?w=2880&amp;quality=70 2x\" media=\"(min-width: 992px)\"\/><source srcset=\"https:\/\/www.capgemini.com\/wp-content\/uploads\/2024\/01\/Next-Gen-clinical-development.jpg?w=1024&amp;quality=70 1x, https:\/\/www.capgemini.com\/wp-content\/uploads\/2024\/01\/Next-Gen-clinical-development.jpg?w=1024&amp;quality=70 2x\" media=\"(min-width: 768px)\"\/><source srcset=\"https:\/\/www.capgemini.com\/wp-content\/uploads\/2024\/01\/Next-Gen-clinical-development.jpg?w=768&amp;quality=70 1x, https:\/\/www.capgemini.com\/wp-content\/uploads\/2024\/01\/Next-Gen-clinical-development.jpg?w=768&amp;quality=70 2x\" media=\"(min-width: 0)\"\/><img decoding=\"async\" src=\"https:\/\/www.capgemini.com\/wp-content\/uploads\/2024\/01\/Next-Gen-clinical-development.jpg\" class=\"header-img header-img-d\" alt=\"\" style=\"object-fit:cover;object-position:50% 14.000000000000002%\" loading=\"eager\"\/><\/picture><\/div><div class=\"heroPictureCardHeaderShape\"><\/div><div class=\"container\"><div class=\"row\"><div class=\"col-md-12\"><div class=\"box\"><div class=\"boxTagWrapper\"><div class=\"tagInfo\"><div><span class=\"box-tag\">Healthcare<\/span><\/div><\/div><\/div><div class=\"box-title\"><h1 data-maxlength=\"34\">Impulsando el \u00e9xito y el time-to-market en el desarrollo cl\u00ednico de f\u00e1rmacos<\/h1><\/div><div class=\"inner-row-insight download-btn\"><div class=\"col-md-4 downloadFiles addPadding\"><a class=\"button-download--small\" type=\"download\" href=\"https:\/\/www.capgemini.com\/es-es\/wp-content\/uploads\/sites\/16\/2024\/06\/Next-Gen-Clinical-Development_Life-Sciences_POV_Jan-2024.pdf\" target=\"_blank\" rel=\"noopener noreferrer\" title=\"abrir en una nueva ventana\"><span>Descarga el PoV<\/span><span class=\"type\">437 KB  pdf<\/span><\/a><\/div><\/div><\/div><\/div><\/div><\/div><\/header>\n\n\n\n<section class=\"wp-block-cg-blocks-group undefined section section--article-content\"><div class=\"article-main-content\"><div class=\"container\"><div class=\"row\"><div class=\"col-12 col-md-1\"><nav class=\"article-social\"><ul class=\"social-nav\"><li class=\"ip-order-fb\"><a href=\"https:\/\/www.facebook.com\/sharer\/sharer.php?u=https:\/\/www.capgemini.com\/?post_type=research-and-insight&amp;p=985355\" target=\"_blank\" rel=\"noopener noreferrer\" title=\"abrir en una nueva ventana\"><i aria-hidden=\"true\" class=\"icon-fb\"><\/i><span class=\"sr-only\">Facebook<\/span><\/a><\/li><li class=\"ip-order-tw\"><a href=\"https:\/\/twitter.com\/intent\/tweet?url=https:\/\/www.capgemini.com\/?post_type=research-and-insight&amp;p=985355&amp;text=Driving%20success%20and%20time-to-market%20in%20clinical%20drug%20development\" target=\"_blank\" rel=\"noopener noreferrer\" title=\"abrir en una nueva ventana\"><i aria-hidden=\"true\" class=\"icon-tw\"><\/i><span class=\"sr-only\">Twitter<\/span><\/a><\/li><li class=\"ip-order-li\"><a href=\"https:\/\/www.linkedin.com\/shareArticle?url=https:\/\/www.capgemini.com\/?post_type=research-and-insight&amp;p=985355&amp;text=Driving%20success%20and%20time-to-market%20in%20clinical%20drug%20development\" target=\"_blank\" rel=\"noopener noreferrer\" title=\"abrir en una nueva ventana\"><i aria-hidden=\"true\" class=\"icon-li\"><\/i><span class=\"sr-only\">Linkedin<\/span><\/a><\/li><\/ul><\/nav><\/div><div class=\"col-12 col-md-11 col-lg-10\"><div class=\"article-text article-quote-text\">\n<h3 class=\"wp-block-heading\" id=\"h-son-rapidos-tus-ensayos-clinicos\">\u00bfSon r\u00e1pidos tus ensayos cl\u00ednicos?<\/h3>\n\n\n\n<p>El mercado del desarrollo cl\u00ednico de f\u00e1rmacos est\u00e1 repleto de innovaciones, como las terapias celulares y gen\u00e9ticas, la terap\u00e9utica digital, la medicina personalizada y los biomarcadores, as\u00ed como la integraci\u00f3n de f\u00e1rmacos y dispositivos m\u00e9dicos. Sin embargo, a pesar de estos avances, muchas organizaciones de las ciencias de la vida no son capaces de sacar el m\u00e1ximo partido de ellos.<\/p>\n\n\n\n<p>La innovaci\u00f3n augura una nueva era de oportunidades para las empresas de ciencias de la vida. Sin embargo, tambi\u00e9n a\u00f1adir\u00e1 nuevos niveles de complejidad al proceso de desarrollo, lo que aumentar\u00e1 la necesidad de resolver los principales retos relacionados con el acceso, la velocidad y la eficacia.<\/p>\n\n\n\n<p>A medida que el entorno cl\u00ednico se vuelve m\u00e1s complejo y competitivo, es el momento de adoptar las estrategias transformadoras, las capacidades digitales y de datos avanzadas y los dise\u00f1os de ensayos innovadores que posibilitar\u00e1n una verdadera funci\u00f3n de ensayos cl\u00ednicos de \u00faltima generaci\u00f3n, impulsando el \u00e9xito y el tiempo de comercializaci\u00f3n en todo el ciclo de vida de desarrollo de f\u00e1rmacos.<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/section>\n\n\n\n<section class=\"wp-block-cg-blocks-group undefined section section--article-content\" id=\"quoteWrapper\"><div class=\"article-main-content\"><div class=\"container\"><div class=\"row\"><div class=\"col-12 col-md-11 col-lg-10 offset-md-1 offset-lg-1\"><div class=\"article-text article-quote-text\"><\/div><\/div><\/div><\/div><\/div><\/section>\n","protected":false},"excerpt":{"rendered":"<p>La innovaci\u00f3n augura una nueva era de oportunidades para el desarrollo de f\u00e1rmacos. Sin embargo, tambi\u00e9n a\u00f1adir\u00e1 nuevos niveles de complejidad.<\/p>\n","protected":false},"author":257,"featured_media":558691,"template":"","meta":{"cg_dt_proposed_to":[],"cg_seo_hreflang_relations":"[]","cg_seo_canonical_relation":"","cg_seo_hreflang_x_default_relation":"{\"uuid\":\"5c16fc7f-ca1a-4155-be0c-8aaa439121d2\",\"blogId\":\"\",\"domain\":\"\",\"sitePath\":\"\",\"postLink\":\"\",\"postId\":null,\"isSaved\":true,\"isCrossLink\":false,\"hasCrossLink\":false}","cg_dt_approved_content":true,"cg_dt_mandatory_content":false,"cg_dt_notes":"","cg_dg_source_changed":true,"cg_dt_link_disabled":false,"footnotes":"","related_resource_url":"","related_resource_id":0,"related_resource_size":"","related_resource_type":"","cg_author":0,"_yoast_wpseo_primary_theme":766,"primary_term":"Healthcare","featured_focal_points":"{\"x\":0.59,\"y\":0.22}"},"tags":[795,283],"research-and-insight-type":[85],"theme":[766],"brand":[],"service":[],"industry":[73],"partners":[],"content-group":[],"class_list":["post-558690","research-and-insight","type-research-and-insight","status-publish","has-post-thumbnail","hentry","tag-ciencias-de-la-vida","tag-salud-digital","research-and-insight-type-point-of-view","theme-healthcare","industry-life-sciences"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v22.8 (Yoast SEO v22.8) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Impulsando el \u00e9xito y el time-to-market en el desarrollo cl\u00ednico de f\u00e1rmacos - Capgemini Spain<\/title>\n<meta name=\"description\" content=\"La innovaci\u00f3n augura una nueva era de oportunidades para el desarrollo de f\u00e1rmacos. Sin embargo, tambi\u00e9n a\u00f1adir\u00e1 nuevos niveles de complejidad.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.capgemini.com\/es-es\/investigacion\/biblioteca-de-investigacion\/impulsando-exito-time-to-market-desarrollo-clinico-farmacos\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Impulsando el \u00e9xito y el time-to-market en el desarrollo cl\u00ednico de f\u00e1rmacos\" \/>\n<meta property=\"og:description\" content=\"La innovaci\u00f3n augura una nueva era de oportunidades para el desarrollo de f\u00e1rmacos. Sin embargo, tambi\u00e9n a\u00f1adir\u00e1 nuevos niveles de complejidad.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.capgemini.com\/es-es\/investigacion\/biblioteca-de-investigacion\/impulsando-exito-time-to-market-desarrollo-clinico-farmacos\/\" \/>\n<meta property=\"og:site_name\" content=\"Capgemini Spain\" \/>\n<meta property=\"article:modified_time\" content=\"2025-03-12T06:58:53+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.capgemini.com\/es-es\/wp-content\/uploads\/sites\/16\/2025\/10\/New-Web-preview-global.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"627\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.capgemini.com\/es-es\/investigacion\/biblioteca-de-investigacion\/impulsando-exito-time-to-market-desarrollo-clinico-farmacos\/\",\"url\":\"https:\/\/www.capgemini.com\/es-es\/investigacion\/biblioteca-de-investigacion\/impulsando-exito-time-to-market-desarrollo-clinico-farmacos\/\",\"name\":\"Impulsando el \u00e9xito y el time-to-market en el desarrollo cl\u00ednico de f\u00e1rmacos - Capgemini Spain\",\"isPartOf\":{\"@id\":\"https:\/\/www.capgemini.com\/es-es\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.capgemini.com\/es-es\/investigacion\/biblioteca-de-investigacion\/impulsando-exito-time-to-market-desarrollo-clinico-farmacos\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.capgemini.com\/es-es\/investigacion\/biblioteca-de-investigacion\/impulsando-exito-time-to-market-desarrollo-clinico-farmacos\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.capgemini.com\/es-es\/wp-content\/uploads\/sites\/16\/2024\/06\/Next-Gen-clinical-development.jpg\",\"datePublished\":\"2024-06-26T12:24:05+00:00\",\"dateModified\":\"2025-03-12T06:58:53+00:00\",\"description\":\"La innovaci\u00f3n augura una nueva era de oportunidades para el desarrollo de f\u00e1rmacos. Sin embargo, tambi\u00e9n a\u00f1adir\u00e1 nuevos niveles de complejidad.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.capgemini.com\/es-es\/investigacion\/biblioteca-de-investigacion\/impulsando-exito-time-to-market-desarrollo-clinico-farmacos\/#breadcrumb\"},\"inLanguage\":\"es-ES\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.capgemini.com\/es-es\/investigacion\/biblioteca-de-investigacion\/impulsando-exito-time-to-market-desarrollo-clinico-farmacos\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es-ES\",\"@id\":\"https:\/\/www.capgemini.com\/es-es\/investigacion\/biblioteca-de-investigacion\/impulsando-exito-time-to-market-desarrollo-clinico-farmacos\/#primaryimage\",\"url\":\"https:\/\/www.capgemini.com\/es-es\/wp-content\/uploads\/sites\/16\/2024\/06\/Next-Gen-clinical-development.jpg\",\"contentUrl\":\"https:\/\/www.capgemini.com\/es-es\/wp-content\/uploads\/sites\/16\/2024\/06\/Next-Gen-clinical-development.jpg\",\"width\":2880,\"height\":1800},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.capgemini.com\/es-es\/investigacion\/biblioteca-de-investigacion\/impulsando-exito-time-to-market-desarrollo-clinico-farmacos\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.capgemini.com\/es-es\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Research &amp; insights\",\"item\":\"https:\/\/www.capgemini.com\/es-es\/research-and-insight\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Impulsando el \u00e9xito y el time-to-market en el desarrollo cl\u00ednico de f\u00e1rmacos\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.capgemini.com\/es-es\/#website\",\"url\":\"https:\/\/www.capgemini.com\/es-es\/\",\"name\":\"Capgemini Espa\u00f1a\",\"description\":\"Capgemini\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.capgemini.com\/es-es\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es-ES\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Impulsando el \u00e9xito y el time-to-market en el desarrollo cl\u00ednico de f\u00e1rmacos - Capgemini Spain","description":"La innovaci\u00f3n augura una nueva era de oportunidades para el desarrollo de f\u00e1rmacos. Sin embargo, tambi\u00e9n a\u00f1adir\u00e1 nuevos niveles de complejidad.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.capgemini.com\/es-es\/investigacion\/biblioteca-de-investigacion\/impulsando-exito-time-to-market-desarrollo-clinico-farmacos\/","og_locale":"es_ES","og_type":"article","og_title":"Impulsando el \u00e9xito y el time-to-market en el desarrollo cl\u00ednico de f\u00e1rmacos","og_description":"La innovaci\u00f3n augura una nueva era de oportunidades para el desarrollo de f\u00e1rmacos. Sin embargo, tambi\u00e9n a\u00f1adir\u00e1 nuevos niveles de complejidad.","og_url":"https:\/\/www.capgemini.com\/es-es\/investigacion\/biblioteca-de-investigacion\/impulsando-exito-time-to-market-desarrollo-clinico-farmacos\/","og_site_name":"Capgemini Spain","article_modified_time":"2025-03-12T06:58:53+00:00","og_image":[{"width":1200,"height":627,"url":"https:\/\/www.capgemini.com\/es-es\/wp-content\/uploads\/sites\/16\/2025\/10\/New-Web-preview-global.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.capgemini.com\/es-es\/investigacion\/biblioteca-de-investigacion\/impulsando-exito-time-to-market-desarrollo-clinico-farmacos\/","url":"https:\/\/www.capgemini.com\/es-es\/investigacion\/biblioteca-de-investigacion\/impulsando-exito-time-to-market-desarrollo-clinico-farmacos\/","name":"Impulsando el \u00e9xito y el time-to-market en el desarrollo cl\u00ednico de f\u00e1rmacos - Capgemini Spain","isPartOf":{"@id":"https:\/\/www.capgemini.com\/es-es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.capgemini.com\/es-es\/investigacion\/biblioteca-de-investigacion\/impulsando-exito-time-to-market-desarrollo-clinico-farmacos\/#primaryimage"},"image":{"@id":"https:\/\/www.capgemini.com\/es-es\/investigacion\/biblioteca-de-investigacion\/impulsando-exito-time-to-market-desarrollo-clinico-farmacos\/#primaryimage"},"thumbnailUrl":"https:\/\/www.capgemini.com\/es-es\/wp-content\/uploads\/sites\/16\/2024\/06\/Next-Gen-clinical-development.jpg","datePublished":"2024-06-26T12:24:05+00:00","dateModified":"2025-03-12T06:58:53+00:00","description":"La innovaci\u00f3n augura una nueva era de oportunidades para el desarrollo de f\u00e1rmacos. Sin embargo, tambi\u00e9n a\u00f1adir\u00e1 nuevos niveles de complejidad.","breadcrumb":{"@id":"https:\/\/www.capgemini.com\/es-es\/investigacion\/biblioteca-de-investigacion\/impulsando-exito-time-to-market-desarrollo-clinico-farmacos\/#breadcrumb"},"inLanguage":"es-ES","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.capgemini.com\/es-es\/investigacion\/biblioteca-de-investigacion\/impulsando-exito-time-to-market-desarrollo-clinico-farmacos\/"]}]},{"@type":"ImageObject","inLanguage":"es-ES","@id":"https:\/\/www.capgemini.com\/es-es\/investigacion\/biblioteca-de-investigacion\/impulsando-exito-time-to-market-desarrollo-clinico-farmacos\/#primaryimage","url":"https:\/\/www.capgemini.com\/es-es\/wp-content\/uploads\/sites\/16\/2024\/06\/Next-Gen-clinical-development.jpg","contentUrl":"https:\/\/www.capgemini.com\/es-es\/wp-content\/uploads\/sites\/16\/2024\/06\/Next-Gen-clinical-development.jpg","width":2880,"height":1800},{"@type":"BreadcrumbList","@id":"https:\/\/www.capgemini.com\/es-es\/investigacion\/biblioteca-de-investigacion\/impulsando-exito-time-to-market-desarrollo-clinico-farmacos\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.capgemini.com\/es-es\/"},{"@type":"ListItem","position":2,"name":"Research &amp; insights","item":"https:\/\/www.capgemini.com\/es-es\/research-and-insight\/"},{"@type":"ListItem","position":3,"name":"Impulsando el \u00e9xito y el time-to-market en el desarrollo cl\u00ednico de f\u00e1rmacos"}]},{"@type":"WebSite","@id":"https:\/\/www.capgemini.com\/es-es\/#website","url":"https:\/\/www.capgemini.com\/es-es\/","name":"Capgemini Espa\u00f1a","description":"Capgemini","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.capgemini.com\/es-es\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es-ES"}]}},"theme_term_info":[{"id":766,"name":"Health"}],"industry_term_info":[{"id":73,"name":"Life sciences"}],"services_term_info":[],"partners_term_info":[],"brand_term_info":[],"brand_term":[],"parsely":{"version":"1.1.0","canonical_url":"https:\/\/capgemini.com\/es-es\/investigacion\/biblioteca-de-investigacion\/impulsando-exito-time-to-market-desarrollo-clinico-farmacos\/","smart_links":{"inbound":0,"outbound":0},"traffic_boost_suggestions_count":0,"meta":{"@context":"https:\/\/schema.org","@type":"NewsArticle","headline":"Impulsando el \u00e9xito y el time-to-market en el desarrollo cl\u00ednico de f\u00e1rmacos","url":"https:\/\/www.capgemini.com\/es-es\/investigacion\/biblioteca-de-investigacion\/impulsando-exito-time-to-market-desarrollo-clinico-farmacos\/","mainEntityOfPage":{"@type":"WebPage","@id":"https:\/\/www.capgemini.com\/es-es\/investigacion\/biblioteca-de-investigacion\/impulsando-exito-time-to-market-desarrollo-clinico-farmacos\/"},"thumbnailUrl":"https:\/\/www.capgemini.com\/es-es\/wp-content\/uploads\/sites\/16\/2024\/06\/Next-Gen-clinical-development.jpg?w=150&h=150&crop=1","image":{"@type":"ImageObject","url":"https:\/\/www.capgemini.com\/es-es\/wp-content\/uploads\/sites\/16\/2024\/06\/Next-Gen-clinical-development.jpg"},"articleSection":"Uncategorized","author":[],"creator":[],"publisher":{"@type":"Organization","name":"Capgemini Spain","logo":""},"keywords":["ciencias de la vida","salud digital"],"dateCreated":"2024-06-26T12:24:05Z","datePublished":"2024-06-26T12:24:05Z","dateModified":"2025-03-12T06:58:53Z"},"rendered":"<meta name=\"parsely-title\" content=\"Impulsando el \u00e9xito y el time-to-market en el desarrollo cl\u00ednico de f\u00e1rmacos\" \/>\n<meta name=\"parsely-link\" content=\"https:\/\/www.capgemini.com\/es-es\/investigacion\/biblioteca-de-investigacion\/impulsando-exito-time-to-market-desarrollo-clinico-farmacos\/\" \/>\n<meta name=\"parsely-type\" content=\"post\" \/>\n<meta name=\"parsely-image-url\" content=\"https:\/\/www.capgemini.com\/es-es\/wp-content\/uploads\/sites\/16\/2024\/06\/Next-Gen-clinical-development.jpg?w=150&amp;h=150&amp;crop=1\" \/>\n<meta name=\"parsely-pub-date\" content=\"2024-06-26T12:24:05Z\" \/>\n<meta name=\"parsely-section\" content=\"Uncategorized\" \/>\n<meta name=\"parsely-tags\" content=\"ciencias de la vida,salud digital\" \/>","tracker_url":"https:\/\/cdn.parsely.com\/keys\/capgemini.com\/p.js"},"archive_status":false,"featured_image_src":"https:\/\/www.capgemini.com\/es-es\/wp-content\/uploads\/sites\/16\/2024\/06\/Next-Gen-clinical-development.jpg","featured_image_alt":"","jetpack_sharing_enabled":true,"distributor_meta":false,"distributor_terms":false,"distributor_media":false,"distributor_original_site_name":"Capgemini Spain","distributor_original_site_url":"https:\/\/www.capgemini.com\/es-es","push-errors":false,"tag_names":["Ciencias de la vida","Salud digital"],"featured_image_url":"https:\/\/www.capgemini.com\/es-es\/wp-content\/uploads\/sites\/16\/2024\/06\/Next-Gen-clinical-development.jpg","_links":{"self":[{"href":"https:\/\/www.capgemini.com\/es-es\/wp-json\/wp\/v2\/research-and-insight\/558690","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.capgemini.com\/es-es\/wp-json\/wp\/v2\/research-and-insight"}],"about":[{"href":"https:\/\/www.capgemini.com\/es-es\/wp-json\/wp\/v2\/types\/research-and-insight"}],"author":[{"embeddable":true,"href":"https:\/\/www.capgemini.com\/es-es\/wp-json\/wp\/v2\/users\/257"}],"version-history":[{"count":4,"href":"https:\/\/www.capgemini.com\/es-es\/wp-json\/wp\/v2\/research-and-insight\/558690\/revisions"}],"predecessor-version":[{"id":567860,"href":"https:\/\/www.capgemini.com\/es-es\/wp-json\/wp\/v2\/research-and-insight\/558690\/revisions\/567860"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.capgemini.com\/es-es\/wp-json\/wp\/v2\/media\/558691"}],"wp:attachment":[{"href":"https:\/\/www.capgemini.com\/es-es\/wp-json\/wp\/v2\/media?parent=558690"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.capgemini.com\/es-es\/wp-json\/wp\/v2\/tags?post=558690"},{"taxonomy":"research-and-insight-type","embeddable":true,"href":"https:\/\/www.capgemini.com\/es-es\/wp-json\/wp\/v2\/research-and-insight-type?post=558690"},{"taxonomy":"theme","embeddable":true,"href":"https:\/\/www.capgemini.com\/es-es\/wp-json\/wp\/v2\/theme?post=558690"},{"taxonomy":"brand","embeddable":true,"href":"https:\/\/www.capgemini.com\/es-es\/wp-json\/wp\/v2\/brand?post=558690"},{"taxonomy":"service","embeddable":true,"href":"https:\/\/www.capgemini.com\/es-es\/wp-json\/wp\/v2\/service?post=558690"},{"taxonomy":"industry","embeddable":true,"href":"https:\/\/www.capgemini.com\/es-es\/wp-json\/wp\/v2\/industry?post=558690"},{"taxonomy":"partners","embeddable":true,"href":"https:\/\/www.capgemini.com\/es-es\/wp-json\/wp\/v2\/partners?post=558690"},{"taxonomy":"content-group","embeddable":true,"href":"https:\/\/www.capgemini.com\/es-es\/wp-json\/wp\/v2\/content-group?post=558690"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}